Thuốc mới có tác dụng kéo dài sự sống cho bệnh nhân ung thư tuyến tiền liệt

12:05 28/12/2024

Rakurs là một loại thuốc tác dụng kép, tiêu diệt các di căn xương, kéo dài sự sống cho bệnh nhân ở giai đoạn muộn; cắt hoặc giảm đáng kể cơn đau, giúp bệnh nhân có thể từ bỏ thuốc giảm đau mạnh.

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